Perceptin cancer

Oct 1, 2012 Patients in early-stage HER2-positive breast cancer should remain on Herceptin (trastuzumab) treatment for one year, and not two years or six Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects, interactions and indications

MONDAY, Oct. 20, 2014 (HealthDay News) -- Adding the drug Herceptin to chemotherapy for certain breast cancer patients increases overall survival and

Find information about Herceptin (trastuzumab), a targeted therapy for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.Who is The drug trastuzumab (Herceptin) is used to treat metastatic breast cancer and early breast cancer (including lymph node-positive and some lymph In some cases, health care professionals may use the trade name Herceptin when referring to Trastuzumab is used to treat metastatic (spread) breast cancer

One Year On Herceptin For Breast Cancer Ideal - Medical News Today

Find out about trastuzumab, which is commonly called herceptin , the main targeted therapy used in breast cancer treatment Apr 16, 2014 Herceptin is a drug that improves the way the body fights the breast Around 15 20 of invasive breast cancers have this and are called

May 7, 2014 Cancer cells grow in an uncontrolled fashion. Herceptin works on the surface of the cancer cell by blocking the chemical signals that can Who is Herceptin for Adjuvant Breast Cancer: Herceptin is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor